Abemaciclib metabolite M2-d6

• CAT Number: S000082
• Molecular Formula: C25H22D6F2N8
• Molecular Weight: 484.58
• Purity: ≥95%
• Target: CDK
• IUPAC Name: 5-fluoro-4-[7-fluoro-3-(1,1,1,3,3,3-hexadeuteriopropan-2-yl)-2-methylbenzimidazol-5-yl]-N-[5-(piperazin-1-ylmethyl)pyridin-2-yl]pyrimidin-2-amine
• InChI: InChI=1S/C25H28F2N8/c1-15(2)35-16(3)31-24-19(26)10-18(11-21(24)35)23-20(27)13-30-25(33-23)32-22-5-4-17(12-29-22)14-34-8-6-28-7-9-34/h4-5,10-13,15,28H,6-9,14H2,1-3H3,(H,29,30,32,33)/i1D3,2D3
• InChIKey: IXGZDCRFGCEEBU-WFGJKAKNSA-N
• SMILES: [2H]C([2H])([2H])C(C([2H])([2H])[2H])N1C(=NC2=C1C=C(C=C2F)C3=NC(=NC=C3F)NC4=NC=C(C=C4)CN5CCNCC5)C

Abemaciclib Metabolite M2-d6 is a high-purity deuterated compound used in advanced pharmaceutical research. This isotopically labeled metabolite of Abemaciclib is essential for studies involving CDK4/6 inhibitors, cancer therapeutics, pharmacokinetics, and metabolic pathways. Featuring six deuterium atoms, it ensures precise and reliable analytical results. Its advanced formulation provides enhanced stability and consistency, making it suitable for various experimental setups. Ideal for oncology research and drug development, Abemaciclib Metabolite M2-d6 integrates seamlessly into existing protocols, offering a robust and cost-effective solution for high-precision scientific investigations.